Company Filing History:
1 out of 2,012 
1 out of 512 
1 out of 1,210 
Years Active: 2019
Title: Baptiste Aussedat: Innovator in HIV Vaccine Development
Introduction
Baptiste Aussedat is a notable inventor based in New York, NY, who has made significant contributions to the field of immunology, particularly in the development of vaccines for human immunodeficiency virus (HIV). His innovative work focuses on creating synthetic glycopeptides that can potentially lead to effective HIV-1 vaccines.
Latest Patents
Aussedat holds a patent for "Cyclic HIV-1 Env V3 glycopeptide immunogens." This invention relates to a vaccine for HIV-1, which comprises synthetic V3 glycopeptides. The methods of making and using these immunogens are also detailed in the patent, showcasing his commitment to advancing HIV research.
Career Highlights
Throughout his career, Baptiste Aussedat has worked with prestigious institutions such as Duke University and the Sloan Kettering Institute for Cancer Research. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Barton F. Haynes and Hua-Xin Liao, who have also made significant contributions to HIV research. Their collaborative efforts have furthered the understanding of HIV and the development of potential vaccines.
Conclusion
Baptiste Aussedat's work in the field of HIV vaccine development exemplifies the importance of innovation in addressing global health challenges. His contributions through patents and collaborations highlight the ongoing efforts to combat HIV and improve public health outcomes.